MDS-111 Hemoglobin, Lactate Dehydrogenase, and FACIT-Fatigue Normalization in Pegcetacoplan-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria from Two Phase 3 Clinical Trials
Year: 2022
Type: conference-abstract
Authors: Dharmik Desai, Brian P. Mulherin, Michael Yeh, Mohammed Al-Adhami, Jessica Savage, David Dingli
Institutions: Apellis Pharmaceuticals (United States), Mayo Clinic
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4296529251